The Valley Desk

Clinical trial reportJournal for immunotherapy of cancerPublished

Phase II basket trial of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART) SWOG S1609: the desmoid tumors

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Temple University Hospital, with Temple Health linked by the institution reference. Affiliation source

Publication record

Type
Clinical trial report
Venue
Journal for immunotherapy of cancer
Published
Subject terms
Humans; Prospective Studies; Adolescent; Adult; Aged; Middle Aged; Female; Male; Young Adult; CTLA-4 Antigen; Programmed Cell Death 1 Receptor; Ipilimumab
PubMed ID
39343510
PubMed Central ID
PMC11440191
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal